Twenty‐two novel mutations in the lysosomal α‐glucosidase gene (GAA) underscore the genotype–phenotype correlation in glycogen storage disease type II

Patients with glycogen storage disease type II (GSDII, Pompe disease) suffer from progressive muscle weakness due to acid α‐glucosidase deficiency. The disease is inherited as an autosomal recessive trait with a spectrum of clinical phenotypes. We have investigated 29 cases of GSDII and thereby identified 55 pathogenic mutations of the acid α‐glucosidase gene (GAA) encoding acid maltase. There were 34 different mutations identified, 22 of which were novel. All of the missense mutations and two other mutations with an unpredictable effect on acid α‐glucosidase synthesis and function were transiently expressed in COS cells. The effect of a novel splice‐site mutation was investigated by real‐time PCR analysis. The outcome of our analysis underscores the notion that the clinical phenotype of GSDII is largely dictated by the nature of the mutations in the GAA alleles. This genotype–phenotype correlation makes DNA analysis a valuable tool to help predict the clinical course of the disease. Hum Mutat 23:47–56, 2004. © 2003 Wiley‐Liss, Inc.

[1]  O. Bodamer,et al.  L-alanine supplementation in late infantile glycogen storage disease type II. , 2002, Pediatric neurology.

[2]  M. Kroos,et al.  A rare presentation of childhood pompe disease: cardiac involvement provoked by Epstein-Barr virus infection. , 2002, Pediatrics.

[3]  B. Byrne,et al.  Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). , 2002, Current molecular medicine.

[4]  M. Roig,et al.  Identification of six novel mutations in the acid alpha-glucosidase gene in three Spanish patients with infantile onset glycogen storage disease type II (Pompe disease) , 2002, Neuromuscular Disorders.

[5]  I. Nonaka,et al.  Frequent mutations in Japanese patients with acid maltase deficiency , 2000, Neuromuscular Disorders.

[6]  A. Vulto,et al.  Recombinant human α-glucosidase from rabbit milk in Pompe patients , 2000, The Lancet.

[7]  L. Sandkuijl,et al.  Glycogen Storage Disease Type II: Birth Prevalence Agrees with Predicted Genotype Frequency , 2000, Public Health Genomics.

[8]  M. Kroos,et al.  Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling , 1999, European Journal of Human Genetics.

[9]  R. Hirschhorn,et al.  Frequency of mutations for glycogen storage disease type II in different populations: the Δ525T and Δexon 18 mutations are not generally “common” in white populations , 1999, Journal of medical genetics.

[10]  D. V. Leenen,et al.  Glycogen storage disease type II: identification of a dinucleotide deletion and a common missense mutation in the lysosomal α‐glucosidase gene , 1998 .

[11]  C. Tifft,et al.  The African origin of the common mutation in African American patients with glycogen-storage disease type II. , 1998, American journal of human genetics.

[12]  D. van Leenen,et al.  Mutation detection in glycogen storage-disease type II by RT-PCR and automated sequencing. , 1997, Biochemical and biophysical research communications.

[13]  A. Kahn,et al.  Glycogen-storage disease type II (acid maltase deficiency): identification of a novel small deletion (delCC482+483) in French patients. , 1997, Biochemical and biophysical research communications.

[14]  M. Menaker,et al.  Identification of an E689K substitution as the molecular basis of the human acid α‐glucosidase type 4 allozyme (GAA*4) , 1996, Annals of human genetics.

[15]  J. Shieh,et al.  Identification of a small deletion in one allele of patients with infantile form of glycogen storage disease type II. , 1996, Biochemical and biophysical research communications.

[16]  A. Reuser,et al.  Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. , 1995, Journal of Medical Genetics.

[17]  C. Boerkoel,et al.  Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. , 1995, American journal of human genetics.

[18]  B. Oostra,et al.  The effect of a single base pair deletion (ΔT525) and a C1634T missense mutation (pro545leu) on the expression of lysosomal α-glucosidase in patients with glycogen storage disease type II , 1994 .

[19]  S. Dimauro,et al.  Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation. , 1994, Human molecular genetics.

[20]  A. Reuser,et al.  Deletion of exon 18 is a frequent mutation in glycogen storage disease type II. , 1994, Biochemical and biophysical research communications.

[21]  S. Brooks,et al.  A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII). , 1994, Human molecular genetics.

[22]  L. Y. Wang,et al.  Point mutation in Pompe disease in Chinese , 1994, Journal of Inherited Metabolic Disease.

[23]  B. Oostra,et al.  The conservative substitution Asp-645-->Glu in lysosomal alpha-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II. , 1993, The Biochemical journal.

[24]  J. van Beeumen,et al.  Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation. , 1993, The Journal of biological chemistry.

[25]  K. Hirschhorn,et al.  Identification of a missense mutation in an adult-onset patient with glycogenosis type II expressing only one allele. , 1991, DNA and cell biology.

[26]  C. Warlow,et al.  Acid maltase deficiency presenting with a myopathy and exercise induced urinary incontinence in a 68 year old male. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[27]  L. Hoefsloot,et al.  Characterization of the human lysosomal alpha-glucosidase gene. , 1990, The Biochemical journal.

[28]  F. Martiniuk,et al.  Identification of the base-pair substitution responsible for a human acid alpha glucosidase allele with lower "affinity" for glycogen (GAA 2) and transient gene expression in deficient cells. , 1990, American journal of human genetics.

[29]  F. Martiniuk,et al.  Sequence of the cDNA and 5'-flanking region for human acid alpha-glucosidase, detection of an intron in the 5' untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences. , 1990, DNA and cell biology.

[30]  A. Reuser,et al.  Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells , 1988, Journal of Neurology.

[31]  L. Hoefsloot,et al.  Primary structure and processing of lysosomal alpha‐glucosidase; homology with the intestinal sucrase‐isomaltase complex. , 1988, The EMBO journal.

[32]  D. Swallow,et al.  Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts. , 1987, The Journal of clinical investigation.

[33]  A. Pellicer,et al.  Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Reuser,et al.  Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II. , 1985, The Journal of biological chemistry.

[35]  W. Hwu,et al.  Molecular genetic study of Pompe disease in Chinese patients in Taiwan , 1999, Human mutation.

[36]  N. Raben,et al.  Novel mutations in African American patients with glycogen storage disease type II , 1999 .

[37]  J. Shieh,et al.  Frequent mutation in Chinese patients with infantile type of GSD II in Taiwan: Evidence for a founder effect , 1998, Human mutation.

[38]  J. Smeitink,et al.  Glycogen storage disease type II: Genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry , 1998, Human mutation.

[39]  M. Yacoub,et al.  The identification of five novel mutations in the lysosomal acid a‐(1,4) glucosidase gene from patients with glycogen storage disease type II , 1998 .

[40]  N. Raben,et al.  Glycogenosis type II: A juvenile‐specific mutation with an unusual splicing pattern and a shared mutation in African Americans , 1997, Human mutation.

[41]  A. Reuser,et al.  Glycogenosis type II (acid maltase deficiency) , 1995, Muscle & nerve. Supplement.

[42]  F. Martiniuk,et al.  Mutation at the catalytic site (M519V) in glycogen storage disease type II (Pompe disease) , 1994, Human mutation.

[43]  C. V. van Noorden,et al.  Synthesis and in situ localization of lysosomal alpha-glucosidase in muscle of an unusual variant of glycogen storage disease type II. , 1993, Ultrastructural pathology.

[44]  H. Hers.  α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease) , 1963 .